The following Test Facilities have been inspected by the Swiss Monitoring Authorities. It was found that they were operating in compliance with the GLP Principles at the time they were inspected. The Facilities are in the compliance monitoring programme of the authorities.
According to article 6 paragraph 2 of the Ordinance on Good Laboratory Practice (OGLP), the Test Facilites are re-inspected every two to three years on a routine basis.
The list is regularly updated according to article 14 OGLP. In case of doubt concerning the actual situation of a particular Facility please contact the notification authority for chemicals.
| Test Facilities | Last Inspect. |
Areas of Expertise* |
|---|---|---|
AnaPath Services GmbH
|
Sep 2017 | OTH (histopathology) |
| AO Research Institute Davos 7270 Davos Platz |
June 2018 | OTH (biocompatibility and efficacy studies with medical devices and pharmaceuticals) |
| Arcadis Schweiz AG 8952 Schlieren |
Aug 2019 | ECT, ENF, PCT |
| Bracco Suisse SA 1228 Plan-les-Ouates, Geneva |
Sep 2018 | ACC, TOX |
| b Sys GmbH 4108 Witterswil |
March 2018 | OTH (Electrophysiology) |
| Celerion Switzerland AG 8320 Fehraltorf |
Nov 2018 | ACC |
| F.Hoffmann-La Roche Ltd. Pharma Research 4070 Basel |
Jan 2020 | ACC, MUT, OTH (safety pharmacology, pathology evaluation) |
| Firmenich SA Laboratoire de biodégradation 1211 Genève |
Dec 2018 | OTH (biodegradation) |
| Givaudan SA Ecotoxicology 1214 Vernier |
Jun 2019 | ENF, PCT |
| Idorsia Ltd.4123 Allschwil | Jun 2018 | ACC |
| Innovative Environmental Services (IES) Ltd. 4108 Witterswil |
Aug 2017 | PCT, ECT, ENF, RES, ACC, OTH (in vitro metabolism/dermal penetration) |
| Institute for Biopharmaceutical Research (IBR), Inc. 9548 Matzingen |
July 2019 | ACC, OTH (pharmacokinetics, immunological testing) |
| Intertek (Schweiz) AG TechCenter Reinach 4153 Reinach |
June 2019 | PCT, ACC |
| LKC Switzerland Ltd 4414 Füllinsdorf |
March 2018 | OTH (study direction of multisite residue studies) |
| MSRU Vetsuisse Faculty Zürich 8057 Zürich |
Oct 2019 | TOX, OTH (biocompability and efficacy with medical devices and pharmaceuticals) |
| Novartis Pharma AG PCS/ Project Pathology 4002 Basel |
Feb 2019 | OTH (pathology review) |
| Philip Morris Products S.A. Research and Development PMI Product Testing 2000 Neuchâtel |
Apr 2018 | PCT, MUT, ACC, OTH (in vitro toxicity) |
| SGS M-Scan SA 1228 Plan-les-Ouates |
May 2019 | ACC |
| Swiss BioQuant AG 4153 Reinach |
Apr 2019 | ACC |
| Syngenta Crop Protection AG GLP Testing Facility WMU 4333 Münchwilen |
Nov 2019 | ACC, PCT |
| SYNLAB pharma institute AG 4127 Birsfelden |
Jan 2020 | ACC, OTH (in vitro cytotoxicity) |
Areas of Expertise:
PCT Physical-chemical testing
TOX Toxicity studies
MUT Mutagenicity studies
ECT Environmental toxicity studies on aquatic and terrestrial organisms
ENF Studies on behaviour in water, soil, and air; bioaccumulation
RES Residue studies
EMN Studies on effects on mesocosms and natural ecosystems
ACC Analytical and clinical chemistry testing
OTH Other studies, specify
Last modification 29.01.2019
